Samsrita Labs Ltd

Samsrita Labs Ltd

₹ 17.0 -1.22%
18 May - close price
About

Incorporated in 1996, Samsarita Labs Ltd is
in the business of healthcare services including hospital, diagnostics, Pharma, and Biotechnology (R&D)

Key Points

Products & Services:[1][2]
a) Stem Cell R&D:
Stem Cell Research & Therapy,
Regenerative Medicine, Bio-artificial
organ scaffolds development, nano-biotechnology, Nano-formulation of
cancer Drugs, Molecular genetics,
and Molecular virology, Stem cell
and Cord blood banking
b) New Drug Discovery:
Wilson’s disease, Non-Alcoholic Steatohepatitis (NASH), Neuropathic Pain, Cardiovascular Diseases, Cystinosis, Huntington’s disease
c) RNA Interference:
For developing a new panel of miRNAs
as a novel Bio Marker
d) Medical Devices:
Extra-corporeal liver support devices, Bioengineering implantable humanized nerve conduits, implantable nanochips carrying insulin-producing cells, extra-corporeal devices, etc.
e) Molecular Diagnostics:
DNA, RNA, and chromosomal based tests
and Pre-natal and pre-implantation genetic diagnostics, etc.
f) Contract Research Organization:
Synthetic Chemistry, Medicinal Chemistry, Drug Development, API’s process research, scale-up activity, Natural products research, and Analytical services

  • Market Cap 25.2 Cr.
  • Current Price 17.0
  • High / Low 22.0 / 13.0
  • Stock P/E
  • Book Value 8.45
  • Dividend Yield 0.00 %
  • ROCE -4.58 %
  • ROE -5.51 %
  • Face Value 10.0

Pros

  • Company has reduced debt.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -49.0% over past five years.
  • Company has a low return on equity of 0.03% over last 3 years.
  • Company has high debtors of 38,325 days.
  • Promoter holding has decreased over last 3 years: -5.40%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021
0.00 2.01 0.42 0.35 0.42 0.24 0.01 0.00 0.00 0.00 0.00 0.00
0.00 4.45 1.11 0.95 0.89 0.76 0.32 0.35 0.23 0.07 0.08 0.06
Operating Profit 0.00 -2.44 -0.69 -0.60 -0.47 -0.52 -0.31 -0.35 -0.23 -0.07 -0.08 -0.06
OPM % -121.39% -164.29% -171.43% -111.90% -216.67% -3,100.00%
0.00 0.11 0.00 0.06 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.02 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 0.00 -2.35 -0.69 -0.54 -0.42 -0.48 -0.27 -0.31 -0.19 -0.03 -0.04 -0.02
Tax % 1.28% 0.00% 0.00% 0.00% 14.58% 0.00% 3.23% 0.00% 66.67% 0.00% 0.00%
0.00 -2.32 -0.69 -0.54 -0.42 -0.41 -0.27 -0.30 -0.19 -0.01 -0.04 -0.02
EPS in Rs 0.00 -1.68 -0.47 -0.36 -0.28 -0.28 -0.18 -0.20 -0.13 -0.01 -0.03 -0.01
Raw PDF
Upcoming result date: 25 May 2024

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
1.28 0.58 1.90 1.43 0.01 0.02 0.02
1.86 1.71 4.34 3.62 0.92 0.43 1.01
Operating Profit -0.58 -1.13 -2.44 -2.19 -0.91 -0.41 -0.99
OPM % -45.31% -194.83% -128.42% -153.15% -9,100.00% -2,050.00% -4,950.00%
0.01 0.03 0.11 0.16 0.15 1.91 0.29
Interest 0.00 0.00 0.01 0.01 0.00 0.00 0.00
Depreciation 0.01 0.01 0.02 0.02 0.01 0.01 0.00
Profit before tax -0.58 -1.11 -2.36 -2.06 -0.77 1.49 -0.70
Tax % -124.14% 5.41% 1.27% 3.40% 0.00% 0.00% 0.00%
-1.31 -1.05 -2.33 -1.98 -0.77 1.49 -0.71
EPS in Rs -1.28 -0.89 -1.69 -1.34 -0.52 1.01 -0.48
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: -49%
3 Years: -76%
TTM: 0%
Compounded Profit Growth
10 Years: %
5 Years: 6%
3 Years: 18%
TTM: -148%
Stock Price CAGR
10 Years: %
5 Years: -12%
3 Years: -20%
1 Year: -17%
Return on Equity
10 Years: %
5 Years: -7%
3 Years: 0%
Last Year: -6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity Capital 10.26 11.76 13.81 14.81 14.81 14.81 14.81
Reserves -2.39 -1.93 -2.11 -3.03 -3.66 -1.58 -2.29
6.50 6.81 7.92 8.58 2.34 2.74 2.08
4.88 6.26 6.61 7.85 3.09 1.16 0.96
Total Liabilities 19.25 22.90 26.23 28.21 16.58 17.13 15.56
0.46 0.36 0.26 0.13 0.02 0.01 0.01
CWIP 14.85 16.13 17.77 18.99 3.26 3.26 3.26
Investments 0.01 0.01 0.01 0.01 4.22 4.80 4.80
3.93 6.40 8.19 9.08 9.08 9.06 7.49
Total Assets 19.25 22.90 26.23 28.21 16.58 17.13 15.56

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-0.26 -3.32 -2.96 -1.05 -0.34 -0.40 0.66
-1.09 -1.19 -1.55 -1.11 -0.23 0.00 0.00
1.27 4.83 4.19 2.17 0.55 0.40 -0.67
Net Cash Flow -0.08 0.32 -0.32 0.01 -0.02 0.01 0.00

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 932.46 1,806.12 424.55 556.43 78,110.00 38,690.00 38,325.00
Inventory Days 0.00 0.00 0.00
Days Payable
Cash Conversion Cycle 932.46 1,806.12 424.55 556.43 78,110.00 38,690.00 38,325.00
Working Capital Days 738.55 2,026.38 733.84 727.45 146,000.00 108,770.00 84,132.50
ROCE % -5.65% -10.57% -8.53% -4.07% 10.12% -4.58%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
58.27% 58.27% 58.27% 52.87% 52.87% 52.87% 52.87% 52.87% 52.87% 52.87% 52.87% 52.87%
41.73% 41.73% 41.73% 47.13% 47.13% 47.13% 47.13% 47.13% 47.13% 47.12% 47.13% 47.13%
No. of Shareholders 6386538641,2301,2221,2151,2661,3171,4191,5871,7602,115

Documents